Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 8 results
Author
Title
Type
Year
Filters:
Author
is
Bismar, Tarek A
[Clear All Filters]
Journal Article
Shah RB
,
Mehra R
,
Chinnaiyan AM
,
Shen R
,
Ghosh D
,
Zhou M
,
Macvicar GR
,
Varambally S
,
Harwood J
,
Bismar TA
et al.
. 2004.
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.
.
Cancer Res. 64(24):9209-16.
Mosquera J-M
,
Perner S
,
Genega EM
,
Sanda M
,
Hofer MD
,
Mertz KD
,
Paris PL
,
Simko J
,
Bismar TA
,
Ayala G
et al.
. 2008.
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
.
Clin Cancer Res. 14(11):3380-5.
Mosquera JMiguel
,
Beltran H
,
Park K
,
MacDonald TY
,
Robinson BD
,
Tagawa ST
,
Perner S
,
Bismar TA
,
Erbersdobler A
,
Dhir, iv R
et al.
. 2013.
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
.
Neoplasia. 15(1):1-10.
Rubin MA
,
Bismar TA
,
Andrén O
,
Mucci L
,
Kim R
,
Shen R
,
Ghosh D
,
Wei JT
,
Chinnaiyan AM
,
Adami H-O
et al.
. 2005.
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
.
Cancer Epidemiol Biomarkers Prev. 14(6):1424-32.
Bismar TA
,
Demichelis F
,
Riva A
,
Kim R
,
Varambally S
,
He L
,
Kutok J
,
Aster JC
,
Tang J
,
Kuefer R
et al.
. 2006.
Defining aggressive prostate cancer using a 12-gene model.
.
Neoplasia. 8(1):59-68.
Rickman DS
,
Chen Y-B
,
Banerjee S
,
Pan Y
,
Yu J
,
Vuong T
,
Perner S
,
Lafargue CJ
,
Mertz KD
,
Setlur SR
et al.
. 2010.
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.
.
Neoplasia. 12(12):1031-40.
Hofer MD
,
Kuefer R
,
Huang W
,
Li H
,
Bismar TA
,
Perner S
,
Hautmann RE
,
Sanda MG
,
Gschwend JE
,
Rubin MA
. 2006.
Prognostic factors in lymph node-positive prostate cancer.
.
Urology. 67(5):1016-21.
Perner S
,
Mosquera J-M
,
Demichelis F
,
Hofer MD
,
Paris PL
,
Simko J
,
Collins C
,
Bismar TA
,
Chinnaiyan AM
,
De Marzo AM
et al.
. 2007.
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.
.
Am J Surg Pathol. 31(6):882-8.